Jane Street Group, LLC Kronos Bio, Inc. Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.73 - $1.38 $43,273 - $81,805	59,279 Added 322.01%	77,688 $96,000
Q1 2024 May 15, 2024	SELL	$1.02 - $1.3 $683 - $871	-670 Reduced 3.51%	18,409 $23,000
Q4 2023 Feb 14, 2024	SELL	$0.75 - $1.49 $9,545 - $18,963	-12,727 Reduced 40.01%	19,079 $23,000
Q3 2023 Nov 14, 2023	BUY	$1.23 - $2.25 $22,820 - $41,744	18,553 Added 139.99%	31,806 $41,000
Q2 2023 Aug 14, 2023	BUY	$1.24 - $1.92 $16,433 - $25,445	13,253 New	13,253 $22,000
Q4 2022 Feb 14, 2023	BUY	$1.44 - $3.44 $33,927 - $81,049	23,561 New	23,561 $38,000

19.8M

9.3K

100

Ticker KRON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,769,100
Market Cap $53.9M
Description
Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.